ASH
Ashland Inc.
$63.70
-2.03 (-3.09%)
At close · Jul 8
Market Cap
$2.92B
Shares
45,787,777
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.82B
-13.7%
FY2025
Net Income
-$845M
-600%
FY2025
Gross Margin
30.1%
+0.8pp
FY2025
Operating Margin
-42.49%
-41.3pp
FY2025
Diluted EPS
-$18.23
-642.6%
FY2025
Operating Cash Flow
$134M
-71%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.84B – $1.87B | $1.81B | $1.82B | $2.11B | $2.19B | $2.39B | $2.11B | $2.02B | $2.15B | $2.59B | $2.31B | $3.02B | $3.42B | $6.1B | |
| — | -$20M | -$33M | $24M | -$6M | -$149M | -$56M | -$119M | -$99M | -$102M | -$229M | -$173M | -$174M | -$166M | |
| — | $1.27B | $1.28B | $1.5B | $1.52B | $1.56B | $1.44B | $1.42B | $1.5B | $1.73B | $1.58B | $2.13B | $2.53B | $4.61B | |
| — | $543M | $549M | $618M | $668M | $830M | $670M | $599M | $651M | $863M | $729M | $887M | $888M | $1.52B | |
| — | — | 30.1% | 29.25% | 30.49% | 34.71% | 31.74% | 29.71% | 30.31% | 33.33% | 31.57% | 29.38% | 25.96% | 24.85% | |
| — | $54M | $54M | $55M | $51M | $55M | $50M | $56M | $58M | $73M | $73M | $87M | $99M | $114M | |
| — | $346M | $344M | $404M | $365M | $393M | $358M | $400M | $426M | $599M | $610M | $858M | $692M | $1.36B | |
| — | $61M | $63M | $76M | $93M | $94M | $90M | $84M | $85M | $93M | $80M | $76M | $78M | $89M | |
| — | — | $237M | $274M | $243M | $241M | $244M | $235M | $277M | $277M | $265M | $302M | $306M | $393M | |
| — | — | — | — | — | — | — | — | — | — | $1M | — | — | $99M | |
| — | -$614M | -$775M | -$26M | $172M | $333M | $192M | -$461M | $86M | $102M | $49M | -$50M | $112M | $46M | |
| — | — | -42.49% | -1.23% | 7.85% | 13.93% | 9.1% | -22.87% | 4% | 3.94% | 2.12% | -1.66% | 3.27% | 0.75% | |
| — | — | -$538M | $248M | $415M | $574M | $436M | -$226M | $363M | $379M | $314M | $252M | $418M | $439M | |
| — | — | — | — | — | — | — | — | — | $1M | $0 | $1M | -$3M | -$25M | |
| — | — | $5M | $8M | $5M | -$2M | $10M | $10M | $7M | $10M | $11M | — | — | — | |
| — | -$634M | -$809M | -$24M | $160M | $206M | $135M | -$577M | -$9M | $11M | -$196M | -$308M | -$151M | -$116M | |
| — | $51M | $13M | -$223M | -$8M | $25M | -$38M | -$22M | $30M | -$8M | -$16M | -$25M | -$139M | -$188M | |
| — | -$707M | -$845M | $169M | $178M | $927M | $220M | -$508M | $505M | $114M | $1M | -$29M | $309M | $233M | |
| — | — | -46.33% | 8% | 8.12% | 38.77% | 10.42% | -25.2% | 23.51% | 4.4% | 0.04% | -0.96% | 9.04% | 3.82% | |
| — | — | — | — | — | — | — | — | $0 | $0 | $27M | $1M | $0 | $0 | |
| — | — | — | — | — | — | — | — | $420M | $45M | $93M | -$12M | -$89M | $52M | |
| USD/shares | — | — | -$18.23 | $3.40 | $3.36 | $16.71 | $3.63 | -$8.39 | $8.15 | $1.82 | $0.01 | -$0.47 | $4.54 | $3.04 |
| USD/shares | — | — | -$18.23 | $3.36 | $3.31 | $16.41 | $3.59 | -$8.39 | $8.15 | $1.79 | $0.01 | -$0.47 | $4.54 | $3.00 |
| shares | — | — | 46M | 49M | 53M | 55M | 60M | 61M | 62M | 63M | 62M | 63M | 68M | 77M |
| shares | — | — | 46M | 50M | 54M | 56M | 61M | 61M | 62M | 64M | 62M | 63M | 68M | 78M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2025: $3.48B in buybacks, $935M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|
| Life Sciences | $641,000,000 | $810,000,000 | $869,000,000 | $815,000,000 | $737,000,000 | $708,000,000 | $732,000,000 | $731,000,000 |
| Personal Care and Household | $577,000,000 | $634,000,000 | $598,000,000 | $678,000,000 | $592,000,000 | $615,000,000 | $651,000,000 | $702,000,000 |
| Personal Care | $577,000,000 | $634,000,000 | $598,000,000 | $678,000,000 | $592,000,000 | $615,000,000 | — | — |
| Specialty Additives | $511,000,000 | $572,000,000 | $600,000,000 | $719,000,000 | $655,000,000 | $589,000,000 | $654,000,000 | $686,000,000 |
| Intermediates and Solvents | $137,000,000 | $144,000,000 | $185,000,000 | $256,000,000 | $178,000,000 | $129,000,000 | $160,000,000 | $155,000,000 |
| Intermediates | $137,000,000 | $144,000,000 | $185,000,000 | $256,000,000 | $178,000,000 | $129,000,000 | — | — |
| Consumer Specialties | — | — | — | — | — | $1,323,000,000 | $1,383,000,000 | $1,433,000,000 |
| Industrial Specialties | — | — | — | — | — | $899,000,000 | $999,000,000 | $1,037,000,000 |
| Performance Adhesives | — | — | — | — | — | $310,000,000 | $345,000,000 | $351,000,000 |
By Geography (USD)
| Component | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|
| Non Us | $1,360,000,000 | $1,489,000,000 | $1,557,000,000 | $1,660,000,000 | $1,474,000,000 | $1,393,000,000 | $1,474,000,000 | $1,592,000,000 |
| United States | $464,000,000 | $624,000,000 | $634,000,000 | $731,000,000 | $637,000,000 | $623,000,000 | $674,000,000 | $997,000,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|
| Personal Care and Household | $90,000,000 | $73,000,000 | $52,000,000 | $102,000,000 | $73,000,000 | -$296,000,000 | $85,000,000 | $105,000,000 |
| Intermediates and Solvents | $8,000,000 | $29,000,000 | $50,000,000 | $87,000,000 | $35,000,000 | -$10,000,000 | $28,000,000 | $25,000,000 |
| Life Sciences | -$262,000,000 | $168,000,000 | $172,000,000 | $155,000,000 | $130,000,000 | $123,000,000 | $114,000,000 | $117,000,000 |
| Unallocated and Other | -$273,000,000 | -$264,000,000 | -$112,000,000 | -$114,000,000 | -$107,000,000 | -$146,000,000 | -$159,000,000 | -$261,000,000 |
| Specialty Additives | -$338,000,000 | -$32,000,000 | $10,000,000 | $103,000,000 | $61,000,000 | -$132,000,000 | $18,000,000 | $64,000,000 |
| Consumer Specialties | — | — | — | — | — | — | — | $222,000,000 |
| Industrial Specialties | — | — | — | — | — | — | — | $116,000,000 |
| Performance Adhesives | — | — | — | — | — | — | — | $52,000,000 |
Operating Margin by Segment (%)
| Component | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|
| Life Sciences | -40.9% | 20.7% | 19.8% | 19% | 17.6% | 17.4% | 15.6% | 16% |
| Personal Care and Household | 15.6% | 11.5% | 8.7% | 15% | 12.3% | -48.1% | 13.1% | 15% |
| Specialty Additives | -66.1% | -5.6% | 1.7% | 14.3% | 9.3% | -22.4% | 2.8% | 9.3% |
| Intermediates and Solvents | 5.8% | 20.1% | 27% | 34% | 19.7% | -7.8% | 17.5% | 16.1% |
| Consumer Specialties | — | — | — | — | — | — | — | 15.5% |
| Industrial Specialties | — | — | — | — | — | — | — | 11.2% |
| Performance Adhesives | — | — | — | — | — | — | — | 14.8% |